GlassScriptPhysician profile
Kevin D Plancher
NPI 1093765950
$193,104.65
in general payments reported to CMS, 2019-2025
36 companies · $54K in 2025
The $54K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,463 · 2021: $1,813 · 2022: $17K · 2023: $25K · 2024: $82K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $13K · Food and Beverage: $5,288 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Entertainment: $37.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,188.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,305.00 |
| Travel and Lodging | $13,054.62 |
| Food and Beverage | $5,287.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Entertainment | $37.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $62,846.37 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $47,595.51 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $27,914.37 | 2019-2025 | Zilretta, Exparel, Iovera |
| Collagen Matrix, INC | $16,329.17 | 2019-2024 | |
| Uoc USA INC | $10,304.73 | 2023-2025 | U2, Conformity, U-Motion II and Ustar II, U2, Psa, Conformity, Uts, U-Motion II and Ustar II, U-Star, Conformity, U2 |
| Anika Therapeutics, INC. | $7,782.76 | 2019-2020 | |
| Aesculap Biologics, LLC | $3,224.97 | 2019-2024 | Novocart 3d |
| Zimmer Biomet Holdings, INC. | $2,610.39 | 2023-2025 | Oss Orthopedic Salvage System, Rosa |
| Heron Therapeutics, INC. | $2,475.17 | 2019 | |
| Synthes Gmbh | $2,460.20 | 2023 | |
| Bioventus LLC | $1,832.78 | 2021-2022 | |
| Gotham Surgical Solutions & Devices, INC. | $1,381.14 | 2021-2025 | |
| Smith+Nephew, INC. | $1,066.01 | 2019-2025 | Journey II, Real Intelligence, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Averitas Pharma INC. | $925.00 | 2024 | |
| Pacira Therapeutics, INC. | $897.21 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $590.31 | 2019-2023 | Biobrace 23mm, Livatec Knee Preservation System |
| Joint Restoration Foundation, INC. | $400.00 | 2022 | |
| Stryker Corporation | $334.45 | 2023-2024 | Aequalis Perform Reversed, Axsos |
| Arthrex, INC. | $331.53 | 2019-2021 | |
| Miach Orthopaedics, INC. | $309.87 | 2022 | |
| Medacta USA, INC. | $267.00 | 2022-2025 | Primary Shoulder |
| Vericel Corporation | $236.09 | 2024-2025 | Maci |
| Geistlich Pharma, North America, INC. | $160.00 | 2023 | Derma-Gide |
| Conformis, INC. | $152.02 | 2023 | Actera Hip Stem, Identity Imprint Knee Replacement System |
| Catalyst Orthoscience | $127.79 | 2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Kuros Biosciences USA, INC | $95.24 | 2023 | |
| Depuy Synthes Sales INC. | $81.13 | 2019 | |
| Horizon Therapeutics Plc | $57.86 | 2019 | |
| Biorez, INC. | $45.70 | 2022 | |
| Trice Medical, INC. | $44.17 | 2019 | |
| Kerecis Limited | $39.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Terumo Bct, INC. | $28.82 | 2019 | |
| Tricoast Surgical Solutions LLC | $26.62 | 2023 | |
| Convatec INC. | $16.37 | 2024 | |
| Medical Device Business Services, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$225,700.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Plancher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.